Prevalence of chronic kidney disease in type 2 diabetes in MaharajNakhon Si ThammaratHospital


  • อัจฉรา เจริญพิริยะ
  • อุดมศักดิ์ แซ่โง้ว
  • งามจิต คงทน


type 2 diabetes Mellitus, Chronic kidney disease, Prevalence, Risk factors


Background : No study was to determine the prevalence of chronic kidney disease in Type 2 diabetes and to identify independent risk factors associated with the presence of decreased kidney function in MaharajNakhon Si Thammarat Hospital.
Objectives : To determine the prevalence of chronic kidney disease in type2 diabetes in MaharajNakhon Si Thammarat Hospital and risk factors which influence kidney function in type 2 diabetes.
Materials and methods : A retrospective study of type 2 diabetes mellitus patients who attended the medicine clinic at MaharajNakhon Si Thammarat Hospital from 1 January 2016 – 31 May 2016.
Results : A total of 3461 adult type2 diabetic patients had CKD 1018 (29.4%):21.7% with stage 3 (12.8% with stage 3a and 8.9% with stage 3b),4.2% with stages 4 and 3.5% with stage 5. Estimated GFR was calculated by CKD-EPI formula. The prevalence of these patients with albuminuria was 44.8% (12.4% microalbuminuria and 32.4% macroalbuminuria). The following variables were significantly associated with CKD were age, duration of diabetes
mellitus, waist circumference,a previous history of hypertension or cardiovascular disease.
Conclusions : Chronic kidney disease is highly prevalent among adult diabetic outpatients attending in MaharajNakhon Si Thammarat Hospital,Clinical characteristic in present study demonstrated as a tertiary health care setting. Intensive and optimal treatment of diabetes to slow the progression of long-term complications should be effectively managed by a disciplinary team.


1. Amos, A.F., D.J. McCarty, and P. Zimmet, The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med;1997. 14 Suppl 5: p. S1-85.

2. Rekkedal G.[WHO world health report 1997]. Tidsskr Sykepl; 1997. 85(9): p. 37-9.

3. Aekplakorn W. Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care; 2011. 34(9): p. 1980-5.

4. Ong-Ajyooth L. Prevalence of chronic kidney disease in Thai adults: a national health survey. BMC Nephrol; 2009. 10: p. 35.

5. Chittinandana A, W. Chailimpamontree, P. Chaloeiphap, Prevalence of chronic kidney disease in Thai adult population. J Med Assoc Thai; 2006. 89 Suppl 2: p. S112-20.

6. Domrongkitchaiporn, S. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol;2005. 16(3): p. 791-9.

7. Laliberte F. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm; 2009. 15(4): p. 312-22.

8. Narenpitak S. and A. Narenpitak. Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand. J Med Assoc Thai; 2008. 91(10): p. 1505-13.

9. Afkarian M. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol; 2013. 24(2): p. 302-8.

10. Praditpornsilpa K. Thailand renal replacement therapy ; 2012.

11. Kasemsup V. Budget impact analysis of including renal replacement therapy in the benefit package of universal coverage in Thailand J Nephrol Soc Thai; 2006. 12(2): p. 136-48.

12. International Classification of Diseases (ICD). World Health Organization.

13. Levey A.S. A new equation to estimate glomerular filtration rate. Ann Intern Med; 2009. 150(9): p. 604-12.

14. Standards of medical care in diabetes. Diabetes Care ;2016. 39(1): p. 1-119.

15. Rodriguez-Poncelas, A. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrol; 2013.14: p. 46.

16. New J.P. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med; 2007. 24(4): p. 364-9.

17. Ngarmukos C. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy. J Med Assoc Thai;2006. 89 Suppl 1: p. S37-42.

18. Krairittichai U. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus. J Med Assoc Thai; 2011. 94 Suppl 2: p. S1-5.

19. Janmohamed M.N. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol; 2013. 14: p. 183.

20. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis, 2007;49(2 Suppl 2): p. S12-154.

21. standards of medical care in diabetes 2017. diabetes care; 2017. 40(1): p. 132.

22. Remuzzi G., M. Macia, and P. Ruggenenti, Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol; 2006. 17(4 Suppl 2): p. S90-7.

23. Haller, H. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med; 2011. 364(10): p. 907-17.




How to Cite

เจริญพิริยะ อ., แซ่โง้ว อ., & คงทน ง. (2017). Prevalence of chronic kidney disease in type 2 diabetes in MaharajNakhon Si ThammaratHospital. Region 11 Medical Journal, 31(1), 73–82. Retrieved from



Original articles